Viewing Study NCT06128551


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-05-29 @ 11:58 AM
Study NCT ID: NCT06128551
Status: RECRUITING
Last Update Posted: 2025-03-27
First Post: 2023-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of RMC-6291 in Combination with RMC-6236 in Participants with Advanced KRAS G12C Mutant Solid Tumors
Sponsor: Revolution Medicines, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer (NSCLC) View
None Colorectal Cancer View
None Pancreatic Ductal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RMC-6291 View
None RAS (ON) View
None KRAS View
None KRASG12C View
None KRASG12C (ON) View
None Targeted therapy View
None Metastatic Cancer View
None Lung Cancer View
None Lung Neoplasms View
None Thoracic Neoplasms View
None Non-small Cell Lung Cancer View
None Carcinoma, Non-Small Cell Lung View
None NSCLC View
None Colorectal Cancer View
None Colonic Neoplasms View
None CRC View
None Appendiceal Cancer View
None KRAS mutation View
None STK11/LKB1 View
None KEAP1 View
None Bronchial neoplasms View
None Respiratory tract neoplasms View
None Neoplasms by site View
None Neoplasms View
None Colon Cancer View
None Rectal Cancer View
None Lung disease View
None Respiratory tract diseases View
None Pancreatic Cancer View
None Carcinoma, Pancreatic Ductal View
None PDAC View
None Gastrointestinal Neoplasms View
None Intestinal Neoplasms View
None Esophageal Cancer View
None Ampullary Cancer View
None Gastric Cancer View
None Gynecological Cancer View
None Ovarian Cancer View
None Endometrial Cancer View
None RMC-6236 View